Reversal of Multidrug Resistance by Symmetrical Selenoesters in Colon Adenocarcinoma Cells
- PMID: 36839934
- PMCID: PMC9967742
- DOI: 10.3390/pharmaceutics15020610
Reversal of Multidrug Resistance by Symmetrical Selenoesters in Colon Adenocarcinoma Cells
Abstract
Recently, selenium containing derivatives have attracted more attention in medicinal chemistry. In the present work, the anticancer activity of symmetrical selenoesters was investigated by studying the reversal of efflux pump-related and apoptosis resistance in sensitive and resistant human colon adenocarcinoma cells expressing the ABCB1 protein. The combined effect of the compounds with doxorubicin was demonstrated with a checkerboard assay. The ABCB1 inhibitory and the apoptosis-inducing effects of the derivatives were measured with flow cytometry. Whole transcriptome sequencing was carried out on Illumina platform upon the treatment of resistant cells with the most potent derivatives. One ketone and three methyl ester selenoesters showed synergistic or weak synergistic interaction with doxorubicin, respectively. Ketone selenoesters were the most potent ABCB1 inhibitors and apoptosis inducers. Nitrile selenoesters could induce moderate early and late apoptotic processes that could be explained by their ABCB1 modulating properties. The transcriptome analysis revealed that symmetrical selenoesters may influence the redox state of the cells and interfere with metastasis formation. It can be assumed that these symmetrical selenocompounds possess toxic, DNA-damaging effects due to the presence of two selenium atoms in the molecule, which may be augmented by the presence of symmetrical groups.
Keywords: P-glycoprotein or ABCB1; apoptosis; metastasis; multidrug resistance; selenoesters.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Antitumor Activity of Symmetrical Selenoesters in Doxorubicin Resistant Breast Cancer.Anticancer Res. 2023 Nov;43(11):4865-4872. doi: 10.21873/anticanres.16683. Anticancer Res. 2023. PMID: 37909996
-
Cyano- and Ketone-Containing Selenoesters as Multi-Target Compounds against Resistant Cancers.Cancers (Basel). 2021 Sep 11;13(18):4563. doi: 10.3390/cancers13184563. Cancers (Basel). 2021. PMID: 34572790 Free PMC article.
-
Pharmaceutical and Safety Profile Evaluation of Novel Selenocompounds with Noteworthy Anticancer Activity.Pharmaceutics. 2022 Feb 6;14(2):367. doi: 10.3390/pharmaceutics14020367. Pharmaceutics. 2022. PMID: 35214099 Free PMC article.
-
Selenides and Diselenides: A Review of Their Anticancer and Chemopreventive Activity.Molecules. 2018 Mar 10;23(3):628. doi: 10.3390/molecules23030628. Molecules. 2018. PMID: 29534447 Free PMC article. Review.
-
Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update.Eur J Med Chem. 2022 Sep 5;239:114542. doi: 10.1016/j.ejmech.2022.114542. Epub 2022 Jun 17. Eur J Med Chem. 2022. PMID: 35751979 Review.
References
Grants and funding
- SZTE ÁOK-KKA 2018/270-62-2/University of Szeged, Faculty of Medicine
- GINOP-2.3.2-15-2016-00038/European Union and Hungarian Government
- 01.06.2022.-30.11.2022./Szeged Foundation for Cancer Research (Szegedi Rákkutatásért Alapítvány)
- BO/00158/22/5/Hungarian Academy of Sciences, János Bolyai Research Scholarship
LinkOut - more resources
Full Text Sources